solifenacin succinate has been researched along with quinazolines in 6 studies
| Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 522 | 194 | 343 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | solifenacin succinate (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jangid, AG; Mistri, HN; Pudage, A; Rathod, DM; Shrivastav, PS | 1 |
| Arora, R; Arora, V; Dey, S; Kandhwal, K; Khuroo, AH; Madan, S; Monif, T; Nazarudheen, S; Reyar, S | 1 |
| Barkin, J; Berner, T; Diles, D; Franks, B | 1 |
| Chen, Y; Jian, Z; Li, H; Liao, B; Liu, Q; Wang, K; Yang, T | 1 |
| Rezk, MR; Tantawy, MA; Wadie, M; Weshahy, SA | 1 |
| Abdel-Moety, EM; Marzouk, HM; Rezk, MR; Tantawy, MA; Wadie, M | 1 |
1 review(s) available for solifenacin succinate and quinazolines
| Article | Year |
|---|---|
Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Network Meta-Analysis; Pain; Quinazolines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urological Agents | 2019 |
1 trial(s) available for solifenacin succinate and quinazolines
| Article | Year |
|---|---|
Combining benefits of an adrenergic and a muscarinic blocker in a single formulation - a pharmacokinetic evaluation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Humans; Male; Muscarinic Antagonists; Quinazolines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Therapeutic Equivalency; Urological Agents; Young Adult | 2013 |
4 other study(ies) available for solifenacin succinate and quinazolines
| Article | Year |
|---|---|
Highly sensitive and rapid LC-ESI-MS/MS method for the simultaneous quantification of uroselective alpha1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma.
Topics: Adrenergic alpha-Antagonists; Chromatography, Liquid; Drug Stability; Humans; Male; Methyl Ethers; Muscarinic Antagonists; Propranolol; Quinazolines; Quinuclidines; Reference Standards; Sensitivity and Specificity; Solifenacin Succinate; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tetrahydroisoquinolines | 2008 |
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2015 |
A novel HPLC-DAD method for simultaneous determination of alfuzosin and solifenacin along with their official impurities induced
Topics: Chromatography, High Pressure Liquid; Kinetics; Quinazolines; Reproducibility of Results; Solifenacin Succinate | 2020 |
A sensing platform of molecular imprinted polymer-based polyaniline/carbon paste electrodes for simultaneous potentiometric determination of alfuzosin and solifenacin in binary co-formulation and spiked plasma.
Topics: Aniline Compounds; Carbon; Electrodes; Humans; Ion-Selective Electrodes; Molecular Imprinting; Polymers; Quinazolines; Solifenacin Succinate | 2022 |